DekaBank Deutsche Girozentrale’s Pacific Biosciences PACB Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-73,300	Closed	-$296K	–	1285
2025 Q4	$296K	Hold	73,300	–	–	﹤0.01%	1079
2025 Q3	$90K	Hold	73,300	–	–	﹤0.01%	1244
2025 Q2	$96K	Hold	73,300	–	–	﹤0.01%	1231
2025 Q1	$79K	Hold	73,300	–	–	﹤0.01%	1241
2024 Q4	$135K	Hold	73,300	–	–	﹤0.01%	1209
2024 Q3	$137K	Hold	73,300	–	–	﹤0.01%	1224
2024 Q2	$96K	Hold	73,300	–	–	﹤0.01%	1298
2024 Q1	$272K	Hold	73,300	–	–	﹤0.01%	1105
2023 Q4	$745K	Hold	73,300	–	–	﹤0.01%	958
2023 Q3	$605K	Hold	73,300	–	–	﹤0.01%	975
2023 Q2	$951K	Hold	73,300	–	–	﹤0.01%	895
2023 Q1	$747K	Hold	73,300	–	–	﹤0.01%	935
2022 Q4	$597K	Hold	73,300	–	–	﹤0.01%	999
2022 Q3	$404K	Hold	73,300	–	–	﹤0.01%	1084
2022 Q2	$326K	Hold	73,300	–	–	﹤0.01%	1099
2022 Q1	$707K	Buy	73,300 +6,700	+10%	+$77.1K	﹤0.01%	985
2021 Q4	$1.28M	Buy	66,600 +1,800	+3%	+$43.4K	﹤0.01%	881
2021 Q3	$1.6M	Hold	64,800	–	–	﹤0.01%	777
2021 Q2	$2.3M	Hold	64,800	–	–	0.01%	692
2021 Q1	$1.92M	Hold	64,800	–	–	0.01%	708
2020 Q4	$1.67M	Sell	64,800 -11,200	-15%	-$190K	0.01%	713
2020 Q3	$740K	Buy	+76,000	New	+$438K	﹤0.01%	844
2019 Q4	–	Sell	-92,500	Closed	-$483K	–	1197
2019 Q3	$483K	Buy	92,500 +17,500	+23%	+$97.9K	﹤0.01%	776
2019 Q2	$451K	Buy	75,000 +29,000	+63%	+$203K	﹤0.01%	933
2019 Q1	$213K	Buy	46,000 +8,500	+23%	+$61.5K	﹤0.01%	1031
2018 Q4	$279K	Sell	37,500 -8,500	-18%	-$53.9K	﹤0.01%	926
2018 Q3	$213K	Sell	46,000 -1,000	-2%	-$4.29K	﹤0.01%	1053
2018 Q2	$164K	Hold	47,000	–	–	﹤0.01%	1067
2018 Q1	$102K	Sell	47,000 -1,000	-2%	-$2.6K	﹤0.01%	1055
2017 Q4	$203K	Hold	48,000	–	–	﹤0.01%	938
2017 Q3	$203K	Hold	48,000	–	–	﹤0.01%	944
2017 Q2	$179K	Hold	48,000	–	–	﹤0.01%	937
2017 Q1	$248K	Sell	48,000 -4,000	-8%	-$19.6K	﹤0.01%	825
2016 Q4	$200K	Buy	52,000 +4,000	+8%	+$29.1K	﹤0.01%	826
2016 Q3	$423K	Hold	48,000	–	–	﹤0.01%	696
2016 Q2	$353K	Buy	48,000 +14,500	+43%	+$132K	﹤0.01%	751
2016 Q1	$292K	Sell	33,500 -4,800	-13%	-$47.2K	﹤0.01%	770
2015 Q4	$502K	Buy	38,300 +1,000	+3%	+$8.97K	0.01%	699
2015 Q3	$137K	Buy	37,300 +1,500	+4%	+$7.33K	﹤0.01%	928
2015 Q2	$206K	Buy	35,800 +1,000	+3%	+$5.79K	﹤0.01%	885
2015 Q1	$203K	Sell	34,800 -3,000	-8%	-$20.7K	﹤0.01%	902
2014 Q4	$286K	Sell	37,800 -3,500	-8%	-$22.4K	﹤0.01%	802
2014 Q3	$203K	Buy	41,300 +1,000	+2%	+$5.23K	﹤0.01%	809
2014 Q2	$249K	Hold	40,300	–	–	﹤0.01%	726
2014 Q1	$216K	Buy	40,300 +3,000	+8%	+$19K	﹤0.01%	713
2013 Q4	$195K	Buy	37,300 +3,500	+10%	+$16.1K	﹤0.01%	669
2013 Q3	$187K	Buy	+33,800	New	+$117K	﹤0.01%	675

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

DekaBank Deutsche Girozentrale's PACB Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Pacific Biosciences (PACB) in Q1 2026, closing a stake of 73,300 shares — an estimated $296K sold.

DekaBank Deutsche Girozentrale first reported a position in PACB in Q3 2013 and held it in 47 quarters. The position peaked at $2.3M in Q2 2021. 231 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Pacific Biosciences position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 73,300 Pacific Biosciences shares in Q1 2026, an estimated $296K.
DekaBank Deutsche Girozentrale first reported a position in Pacific Biosciences in Q3 2013 and held it in 47 quarters.
DekaBank Deutsche Girozentrale's Pacific Biosciences position peaked at $2.3M in Q2 2021.
231 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.